Frank R. Oakes's most recent trade in Edesa Biotech Inc was a trade of 20,000 Share Option (right to buy) done . Disclosure was reported to the exchange on July 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | Frank R. Oakes | Director | 20 Jul 2023 | 20,000 | 20,000 | - | - | Share Option (right to buy) | ||
| Edesa Biotech Inc | Frank R. Oakes | Director | 28 Feb 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | ||
| Edesa Biotech Inc | Frank R. Oakes | Director | 22 Apr 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | ||
| Edesa Biotech Inc | Frank R. Oakes | Director | 18 Feb 2021 | 6,165 | 0 (0%) | 0% | 7.2 | 44,696 | Common Shares | |
| Edesa Biotech Inc | Frank R. Oakes | Director | 18 Feb 2021 | 1,827 | 0 (0%) | 0% | 7.3 | 13,246 | Common Shares | |
| Edesa Biotech Inc | Frank R. Oakes | Director | 13 Oct 2020 | 20,000 | 20,000 | - | - | Stock option (right to buy) | ||
| Edesa Biotech Inc | Frank R. Oakes | Director | 06 Oct 2020 | 609 | 1,827 (0%) | 0% | 4 | 2,436 | Common Shares | |
| Edesa Biotech Inc | Frank R. Oakes | Director | 06 Oct 2020 | 609 | 0 | - | - | Common Share Warrants (Right to Buy) |